SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367920-18-000022
Filing Date
2018-05-03
Accepted
2018-05-03 07:30:52
Documents
3
Period of Report
2018-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K q118earningsrelease-8xk.htm 8-K 31541
2 EXHIBIT 99.1 q118earningsrelease.htm EX-99.1 67675
3 concertimage8ka08.jpg GRAPHIC 15744
  Complete submission text file 0001367920-18-000022.txt   122245
Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36310 | Film No.: 18801807
SIC: 2834 Pharmaceutical Preparations